Expert second opinions for patent foramen ovale (pfo). Dual-physician Heart Team review with triple risk scoring. Results in 24 hours.
Patent Foramen Ovale (PFO) ) is a flap-like opening between the upper heart chambers that persists from fetal circulation. If you are facing a decision about patent foramen ovale (pfo), an independent Heart Team second opinion can confirm whether surgery is the right choice and identify alternatives. WhiteGloveMD delivers dual-physician review with STS, EuroSCORE II, and AATS risk scoring in 24 hours. Get an independent second opinion →
A patent foramen ovale (PFO) is a flap-like opening between the upper heart chambers that persists from fetal circulation. Present in approximately 25% of adults, PFOs are usually harmless. However, they can serve as a conduit for blood clots to cross from the venous to the arterial system, potentially causing strokes (paradoxical embolism).
PFO closure decisions are nuanced. Recent trials support closure in select patients under 60 with cryptogenic stroke and high-risk PFO features (atrial septal aneurysm, large shunt). However, attributing a stroke to a PFO requires careful exclusion of other causes. Both over-treatment and under-treatment are common.
Surgery for patent foramen ovale (pfo) depends on symptom severity, imaging findings, and risk profile. Guidelines from the AHA/ACC define specific thresholds, but many patients fall into gray zones where a second opinion meaningfully changes the recommendation. PFO closure decisions are nuanced. Recent trials support closure in select patients under 60 with cryptogenic stroke and high-risk PFO features (atrial septal aneurysm, large shunt). However, attributing a stroke to a PFO requires careful exclusion of other causes. Both over-treatment and under-treatment are common.
Operative mortality for patent foramen ovale (pfo)-related cardiac surgery is calculated using validated models including STS PROM, EuroSCORE II, and AATS. Individual risk depends on age, comorbidities, frailty, ejection fraction, and surgeon/center volume. Our free calculator at whiteglovemd.com/tools/risk-calculator estimates your specific risk across all three models in real time.
Yes. Studies show that 30-40% of expert cardiac surgery second opinions change the original treatment plan — sometimes by recommending less-invasive alternatives, sometimes by clarifying that watchful waiting is safer. WhiteGloveMD pairs a cardiac surgeon and cardiologist with our Clintelligence multi-agent AI pipeline to deliver an independent review in 24 hours, starting at $500.
The optimal treatment for patent foramen ovale (pfo) depends on anatomy, comorbidities, age, and personal goals. PFO closure vs medical therapy after cryptogenic stroke. A Heart Team review evaluates every viable option — including transcatheter approaches, repair vs replacement, and surgeon/center matching — rather than defaulting to a single recommendation.
WhiteGloveMD delivers a dual-physician, AI-augmented second opinion in 24 hours. Starting at $500.